151 related articles for article (PubMed ID: 35046638)
1. Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway.
Li H; Luo K; Yang Z; Chen M; Yang X; Wang J; Ying Y; Wu D; Wang Q
Drug Des Devel Ther; 2022; 16():129-141. PubMed ID: 35046638
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancer.
Kang SK; Bae HJ; Kwon WS; Kim TS; Kim KH; Park S; Yu SY; Hwang J; Park J; Chung HC; Rha SY
Cell Oncol (Dordr); 2021 Dec; 44(6):1387-1403. PubMed ID: 34791636
[TBL] [Abstract][Full Text] [Related]
3. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
[TBL] [Abstract][Full Text] [Related]
4. DSC2 Suppresses the Metastasis of Gastric Cancer through Inhibiting the BRD4/Snail Signaling Pathway and the Transcriptional Activity of
Sun C; Wang L; Du DD; Ji JB; Yang XX; Yu BF; Shang PF; Guo XL
Oxid Med Cell Longev; 2022; 2022():4813571. PubMed ID: 36120591
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors.
Li J; Zhang W; Qiu Q; Zhou D; Feng Z; Tong Z; Wei J; Huang W; Li J; Qian H; Shi W
Chem Biol Drug Des; 2021 May; 97(5):1117-1128. PubMed ID: 33638254
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of imidazolopyridone derivatives as novel BRD4 inhibitors.
Yang Y; Chen P; Zhao L; Zhang B; Xu C; Zhang H; Zhou J
Bioorg Med Chem; 2021 Jan; 29():115857. PubMed ID: 33191086
[TBL] [Abstract][Full Text] [Related]
7. Berbamine Exerts Anti-Inflammatory Effects via Inhibition of NF-κB and MAPK Signaling Pathways.
Jia XJ; Li X; Wang F; Liu HQ; Zhang DJ; Chen Y
Cell Physiol Biochem; 2017; 41(6):2307-2318. PubMed ID: 28456802
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 6-phenyl-1,3a,4,10b-tetrahydro-2H-benzo[c]thiazolo[4,5-e]azepin-2-one derivatives as potential BRD4 inhibitors.
Li Q; Li J; Cai Y; Zou Y; Chen B; Zou F; Mo J; Han T; Guo W; Huang W; Qiu Q; Qian H
Bioorg Med Chem; 2020 Aug; 28(15):115601. PubMed ID: 32631570
[TBL] [Abstract][Full Text] [Related]
9. Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.
Liang Y; Qiu X; Xu RZ; Zhao XY
J Zhejiang Univ Sci B; 2011 Jul; 12(7):568-74. PubMed ID: 21726064
[TBL] [Abstract][Full Text] [Related]
10. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.
Liang Y; Xu RZ; Zhang L; Zhao XY
Acta Pharmacol Sin; 2009 Dec; 30(12):1659-65. PubMed ID: 19960011
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
Zheng JF; Guo NH; Zi FM; Cheng J
Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer.
Shen H; Hu X; Yang X; Chen J; Fu Y; He H; Shi Y; Zeng R; Chang W; Zheng S
Med Oncol; 2022 Nov; 40(1):9. PubMed ID: 36352160
[TBL] [Abstract][Full Text] [Related]
13. Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells.
Feng J; Chen X; Wang Y; Du Y; Sun Q; Zang W; Zhao G
Mol Cell Biochem; 2015 Oct; 408(1-2):163-70. PubMed ID: 26112905
[TBL] [Abstract][Full Text] [Related]
14. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel indole derivatives as potential HDAC/BRD4 dual inhibitors and anti-leukemia agents.
Cheng G; Wang Z; Yang J; Bao Y; Xu Q; Zhao L; Liu D
Bioorg Chem; 2019 Mar; 84():410-417. PubMed ID: 30554080
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of novel pyridone derivatives as potent BRD4 inhibitors for the potential treatment of prostate cancer.
Jiang W; Wang X; Shu C; Hou Q; Yang K; Wu X
Bioorg Chem; 2022 Feb; 119():105575. PubMed ID: 34995979
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors.
Xu Y; Zhang XJ; Li WB; Wang XR; Wang S; Qiao XP; Chen SW
Eur J Med Chem; 2020 Dec; 208():112780. PubMed ID: 32883643
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.
Liu W; Lu Y; Chai X; Liu X; Zhu T; Wu X; Fang Y; Liu X; Zhang X
J Exp Clin Cancer Res; 2016 Nov; 35(1):183. PubMed ID: 27887633
[TBL] [Abstract][Full Text] [Related]
20. Circ_0000376 downregulation inhibits the progression of non-small cell lung cancer by mediating the miR-488-3p/BRD4 axis and the PI3K/PKB signaling pathway.
Yuan H; Wu H; Cheng J; Xiong J
Histol Histopathol; 2021 Dec; 36(12):1309-1324. PubMed ID: 34730838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
